Guillermo S. C.
- Country
- Spain
- Department
- Pneumology Department
Research Overview
- A phase 2 trial of Gremubamab compared to placebo in participants with bronchiectasis and chronic Pseudomonas aeruginosa infection
- Efficacy, Safety, and Tolerability of Itepekimab in Non-Cystic Fibrosis Bronchiectasis: A Randomized, Double-Blind, Placebo-Controlled Study
- Efficacy and Safety Evaluation of Amikacin Liposome Inhalation Suspension with Azithromycin and Ethambutol in Adult Patients with MAC-Induced NTM Lung Infection
Data & Insights
Has run more than one trial at 22 of 101 partner sites.
Specializations
Respiratory Diseases
This investigator specializes in treating non-cystic fibrosis bronchiectasis and related respiratory conditions, with particular emphasis on innovative therapeutic approaches for managing bronchial disorders.
- Bronchiectasis Management
- Pulmonary Exacerbations
- Respiratory Infections
Their work extends to investigating treatments for chronic airway conditions and their complications.
Infectious Disease Management
The investigator focuses on treating nontuberculous mycobacterial lung infections and Pseudomonas aeruginosa infections in patients with bronchiectasis.
- Mycobacterium Avium Complex (MAC)
- Bacterial Burden Management
- Chronic Infection Treatment
Their expertise includes evaluating novel antimicrobial approaches for respiratory infections.
Therapeutic Innovation
The investigator evaluates novel therapeutic agents including liposomal formulations and monoclonal antibodies for respiratory conditions.
- Inhaled Therapeutics
- Biological Treatments
- Long-term Treatment Safety
Their research encompasses both established and experimental therapeutic approaches for chronic respiratory conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.